← Leaderboards
Jay M Lee
University Of California Los Angeles
$661,474
Attributed
$661,474
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $133.3K · FY2009–13$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$661,474 · 2
By mechanism
K23$660,155 · 1
M01$1,319 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Sherven Sharma$2,093,761
- Jesse Lawton Clark$8,360,524
- Srinivasa Reddy$11,348,036
- Mansoureh Eghbali$10,436,797
- Alexander M Cole$10,641,954
Others in their field
Top investigators on “Tumor Burden”
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
- Electra D. Paskett · Ohio State University$49,679,221
- David Heimbrook · Leidos Biomedical Research, Inc.$33,160,617
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Monica M Bertagnolli · Strang Cancer Prevention Center$26,036,828
Research focus
Tumor BurdenImmune ResponseMaximum Tolerated DoseTumorSiteInjection Of Therapeutic AgentGenerationsInstitutionSafetySourceDendritic CellsCcl21 GeneResearch PersonnelNon-Small-Cell Lung CarcinomaFundingGene-ModifiedAutologous Dendritic CellsCell PhysiologyAnimalsCareerAutologousAdenoviral-MediatedDendritic Cell TherapyCytokine
Grant awards (6)
Gene Modified Dendritic Cell Therapy in Lung Cancer$132,031
K23 · FY2013 · CA · contact PI
Gene Modified Dendritic Cell Therapy in Lung Cancer$132,031
K23 · FY2012 · CA · contact PI
Gene Modified Dendritic Cell Therapy in Lung Cancer$132,031
K23 · FY2011 · CA · contact PI
Gene Modified Dendritic Cell Therapy in Lung Cancer$132,031
K23 · FY2010 · CA · contact PI
A PHASE I TRIAL OF CCL-21 GENE MODIFIED DENDRITIC CELLS IN NON-SMALL CELL LUNG$1,319
M01 · FY2010 · RR · contact PI
Gene Modified Dendritic Cell Therapy in Lung Cancer$132,031
K23 · FY2009 · CA · contact PI